Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice

Osteoporos Int. 2014 Feb;25(2):397-8. doi: 10.1007/s00198-013-2583-3. Epub 2013 Dec 10.

Authors

A-F Donneau¹, J-Y Reginster

Affiliation

¹ Medical Biostatistics Unit, Department of Public Health Sciences, University of Liège, Liege, Belgium.

No abstract available

Publication types

Editorial

MeSH terms

Bone Density Conservation Agents / adverse effects*
Bone Density Conservation Agents / therapeutic use
Cardiovascular Diseases / chemically induced*
European Union
Humans
Osteoporosis / drug therapy
Pharmacovigilance
Thiophenes / adverse effects*
Thiophenes / therapeutic use

Substances

Bone Density Conservation Agents
Thiophenes
strontium ranelate